SCCM
IBB icon

Schafer Cullen Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Schafer Cullen Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-8,796
Closed -$615K – 349
2013
Q3 		$615K Sell
8,796
-6,600
-43% -$432K 0.01% 252
2013
Q2 		$892K Buy
+15,396
New +$890K 0.01% 221

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Schafer Cullen Capital Management's IBB Position: Q4 2013 in Review

Schafer Cullen Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2013, closing a stake of 8,796 shares — an estimated $615K sold.

Schafer Cullen Capital Management first reported a position in IBB in Q2 2013 and held it in 2 quarters. The position peaked at $892K in Q2 2013. 278 funds tracked by Wall St. Rank hold IBB as of Q4 2013.

  • Schafer Cullen Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2013 after selling out during the quarter.
  • Schafer Cullen Capital Management sold 8,796 iShares Biotechnology ETF shares in Q4 2013, an estimated $615K.
  • Schafer Cullen Capital Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 2 quarters.
  • Schafer Cullen Capital Management's iShares Biotechnology ETF position peaked at $892K in Q2 2013.
  • 278 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2013.

Based on Schafer Cullen Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.